Gene · 9739
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. | Mil Med Res | 2023 | 38044445 | PubTator, text mining | PubMed |
| The SMYD3-dependent H3K4me3 status of IGF2 intensifies local Th2 differentiation in CRSwNP via positive feedback. | Cell Commun Signal | 2023 | 38037054 | PubTator, text mining | PubMed |
| KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11. | Open Med (Wars) | 2023 | 38025523 | PubTator, text mining | PubMed |
| Identification of two novel autism genes, TRPC4 and SCFD2, in Qatar simplex families through exome sequencing. | Front Psychiatry | 2023 | 38025430 | PubTator, text mining | PubMed |
| Role and therapeutic potential of DEAD-box RNA helicase family in colorectal cancer. | Front Oncol | 2023 | 38023215 | PubTator, text mining | PubMed |
| Applying molecular genetic data at different scales to support conservation assessment of European Habitats Directive listed species: A case study of Eurasian otter in Austria. | Evol Appl | 2023 | 38020875 | PubTator, text mining | PubMed |
| Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia. | EMBO J | 2023 | 38010205 | PubTator, text mining | PubMed |
| Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. | Nutrients | 2023 | 38004113 | PubTator, text mining | PubMed |
| In Vivo and In Vitro Characterization of the RNA Binding Capacity of SETD1A (KMT2F). | Int J Mol Sci | 2023 | 38003223 | Swiss-Prot, curated | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival. | Cell Commun Signal | 2023 | 37974198 | PubTator, text mining | PubMed |
| Human-genome single nucleotide polymorphisms affecting transcription factor binding and their role in pathogenesis. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37965371 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
| The CRTC-1 transcriptional domain is required for COMPASS complex-mediated longevity in C. elegans. | Nat Aging | 2023 | 37946042 | PubTator, text mining | PubMed |
| Mesenchymal stem cells under epigenetic control - the role of epigenetic machinery in fate decision and functional properties. | Cell Death Dis | 2023 | 37932257 | PubTator, text mining | PubMed |
| Case report: De novo variant of SETD1A causes infantile epileptic spasms syndrome. | Front Neurol | 2023 | 37928142 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer. | Front Oncol | 2023 | 37909018 | PubTator, text mining | PubMed |
| MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. | EMBO J | 2023 | 37905571 | PubTator, text mining | PubMed |
| Bidirectional relationship between olfaction and Parkinson's disease. | medRxiv | 2023 | 37905151 | PubTator, text mining | PubMed |
| Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer. | Front Oncol | 2023 | 37901333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9739/papers?page=9